Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin. - Wikidata - wikimedia - TriplyDB

Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin.

Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin.

http://www.wikidata.org/entity/Q37275739

about

An overview of long non-coding RNAs in ovarian cancers miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2 NCK Associated Protein 1 Modulated by miRNA-214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia.MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.MicroRNAs: novel players in cancer diagnosis and therapies.The role of microRNAs in ovarian cancer MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.MicroRNA‑126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer.MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets.Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e.MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2.Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.MicroRNAs: master regulators of drug resistance, stemness, and metastasis.The role of miRNAs in cancer: from pathogenesis to therapeutic implications.Restoring TRAIL mediated signaling in ovarian cancer cells.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.MicroRNA-145 contributes to enhancing radiosensitivity of cervical cancer cells.miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance.Current status on microRNAs as biomarkers for ovarian cancer.Polymer nanoparticle delivery of dichloroacetate and DACH-Pt to enhance antitumor efficacy and lower systemic toxicity.MicroRNAs in gynecological cancers: Small molecules with big implications.Fabrication and Characterization of a Stabilized Thin Film Ag/AgCl Reference Electrode Modified with Self-Assembled Monolayer of Alkane Thiol Chains for Rapid Biosensing Applications.Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation.The Network of Non-coding RNAs in Cancer Drug Resistance MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition

P2860

Q26753467-01EFB0A5-138C-431B-9060-2E684D7E684A Q28606716-128D663F-A1D4-4B40-9D40-55964D4F89A1 Q29871102-656DD181-26B5-42C8-92D4-67A65815C51F Q30244282-989412B9-928B-4A52-8B24-ED0FA78D76DE Q33804215-CE62BE33-9EFB-44D7-8EED-0ACA51E3623F Q33850064-3D8CC1D2-C734-4AF2-A9F3-0507E7B211C5 Q33914573-269FDD97-A2DC-403E-8B99-BFC2DD556E48 Q34253436-9660EBCC-8DC4-41AB-B9C2-038F140F75CD Q36214179-B0CEF4AE-FA87-4DD0-8995-A412BC42434E Q36520345-962BC044-9892-486D-9B75-678FCBA1F958 Q37295716-A7513A42-31BE-4E95-87FB-C8D426B66274 Q37335617-45B6AFCB-A2DF-4BFD-9A5E-4E9C081ADA93 Q37641753-6F865AAD-FA22-4BC6-9283-4AC66DED2CB8 Q37732994-BE36B808-F092-4517-A451-BEA887C026C5 Q37736667-D5378C2D-912B-43B3-BAC2-77172F22E9D9 Q38186568-CC9759BE-1A09-42AB-B482-269120D1B240 Q38221290-6A3FEE61-A200-4FA7-B18D-1DC726AA2CD3 Q38230205-67650EB3-95F5-4C9C-87BC-8265258C800D Q38258014-FD01E210-30F0-4155-B917-9FB2A3B41494 Q38301131-C1CAB65A-5CBD-4D7A-A5BE-63E09F482465 Q38366731-C95CC73D-FDAF-4FFB-8544-810E9170EC8D Q38544386-42A69EFE-3511-43D1-A72D-6DEA613E141B Q38546133-DBAE6ACA-3A06-4291-8C7A-6F8AF66A338B Q38633144-C4BEBFAD-73DB-46C1-8B3F-432338F1FA34 Q38711390-BA91CDB9-6AF2-4B3D-A95C-6C18F00B16D5 Q38799444-33379A3E-B69A-4574-A094-DD988EE09EFA Q39333266-8E0B4D9E-0F84-4F04-A453-32692BF79744 Q47159991-ED9B2541-36BC-41A6-A56C-504B05D3FD2E Q47200415-0FDC9E89-4751-4358-B2E2-ED702C1306AA Q52328065-3C950A22-F390-4A71-AFB0-38C9D4E0FA03 Q58694197-0BFEF94C-81CA-4FDA-BB00-A3E7FB381100 Q58795253-401A7382-2285-4FBF-A58B-F0E48E29E376

P2860

Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin.

http://www.wikidata.org/entity/Q37275739

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Deregulation of let-7e in epit ...... nt of resistance to cisplatin.

@en

Deregulation of let-7e in epit ...... nt of resistance to cisplatin.

@nl

type

label

Deregulation of let-7e in epit ...... nt of resistance to cisplatin.

@en

Deregulation of let-7e in epit ...... nt of resistance to cisplatin.

@nl

prefLabel

Deregulation of let-7e in epit ...... nt of resistance to cisplatin.

@en

Deregulation of let-7e in epit ...... nt of resistance to cisplatin.

@nl

P1433

Q37275739-65EE6863-B210-4B6E-82D9-2FC83FB6270E

P1476

Q37275739-D8504EE2-385E-4F04-B185-CF59F360BB1E

P2093

Q37275739-2C5DA5A3-52E2-42B0-9485-DDF0473FC16C

Q37275739-2EC13C41-31C6-424B-96A9-66A841304D07

Q37275739-5020A89C-333E-418C-90CF-D8FAB90F303F

Q37275739-6D0F4EC5-86A4-4B6C-AABF-9A0ABB078A82

Q37275739-77C429A8-D58B-4E49-AC96-D2859EB594A3

Q37275739-78358441-65C4-4B7F-A17D-A0E50089AF10

Q37275739-9D149FA1-D370-4133-A136-EA41B3435F3C

Q37275739-BB995451-1DD4-4DE2-9F3F-78CFD05193C3

P2860

Q37275739-00147996-265A-4D1F-AAD8-F253D2103D9E

Q37275739-0545310E-2844-4D4E-AFF8-1EC6B267B0E9

Q37275739-058DD304-B704-42EE-BCB9-A14DD82548CC

Q37275739-0900CB67-D557-43D1-AB98-2D5EC1184504

Q37275739-152E34A7-5F06-4289-82F0-E620E716CF88

Q37275739-1DB896BC-ABD2-4AEB-9BCA-3DC934B8700B

Q37275739-1DBA69F9-4C04-4E6E-AA7C-BB67130A24F5

Q37275739-1EFB9A7A-280A-4B2B-9866-5C76BCC41622

Q37275739-1FE8CA66-ACC6-4F12-AB80-B8674E64F0C2

Q37275739-3541736F-02AB-4C0A-BF81-B7D4034D7074

P2888

Q37275739-833C226E-DFEA-46E3-A4DD-DDEF2D10F086

P304

Q37275739-DC6AB050-E1AC-4DF6-BBEC-6FEEF6AB43EB

P31

Q37275739-0B6395F9-7785-41EF-AE11-B6A242A8D3B9

P356

Q37275739-CF46178E-BC71-4568-B023-D108C4A8B588

P478

Q37275739-C20ED9BD-70EE-404C-836C-0E9C569282E4

P577

Q37275739-C7BF34D7-15CB-43DD-82AB-880EC38A1093

P5875

Q37275739-39D86240-B18D-448A-AEF0-4C9C7084862C

P698

Q37275739-2622228D-81A1-4F7E-9698-D023656A63CA

P921

Q37275739-1AB8C7A3-ABDB-4A6F-992B-C5A2A8704FB8

P932

Q37275739-FB7B096C-F626-44B2-BED1-B102416A4A5D

P356

P1433

P1476

Deregulation of let-7e in epit ...... nt of resistance to cisplatin.

@en

P2093

C Yang

http://www.w3.org/2001/XMLSchema#string

H Ding

http://www.w3.org/2001/XMLSchema#string

J Cai

http://www.w3.org/2001/XMLSchema#string

J Guo

http://www.w3.org/2001/XMLSchema#string

J Jia

http://www.w3.org/2001/XMLSchema#string

J Wang

http://www.w3.org/2001/XMLSchema#string

Q Yang

http://www.w3.org/2001/XMLSchema#string

Z Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Prediction of mammalian microRNA targets

Combinatorial microRNA target predictions

MicroRNAs: genomics, biogenesis, mechanism, and function

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

P2888

P304

e75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONCSIS.2013.39

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257530514

http://www.w3.org/2001/XMLSchema#string

P698

24100610

http://www.w3.org/2001/XMLSchema#string

P921

P932

3816216

http://www.w3.org/2001/XMLSchema#string